Structural bioinformatics: From the sequence to structure and function

Current Bioinformatics

Volumn 4, Issue 1, 2009, Pages 54-83

  Wiltgen, Marco ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Density functional theory; Homology modelling; Molecular medicine; Protein data base; Protein structures; Protein visualization; Voronoi tessellation

Indexed keywords

BIOINFORMATICS; CLINICAL RESEARCH; DATA VISUALIZATION; DIAGNOSIS; DISEASE CONTROL; MOLECULES; PROTEINS; STRUCTURAL ANALYSIS; THREE DIMENSIONAL COMPUTER GRAPHICS; VISUALIZATION;

DATA BASE; DENSITY-FUNCTIONAL-THEORY; HOMOLOGY MODELING; MOLECULAR MEDICINE; PROTEIN DATA; PROTEIN DATA BASE; PROTEIN VISUALIZATIONS; PROTEINS STRUCTURES; STRUCTURAL BIOINFORMATICS; VORONOI TESSELLATIONS;

DENSITY FUNCTIONAL THEORY;

4 [5 (4 BROMOPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; ACETYLSALICYLIC ACID; AMINO ACID; ANTINEOPLASTIC AGENT; CARBON MONOXIDE; CASPASE INHIBITOR; CISPLATIN; CYTOCHROME P450; ERYTHROPOIETIN; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 8; ION CHANNEL; LACTATE DEHYDROGENASE; LOPINAVIR; MESSENGER RNA; MYOGLOBIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; PEPTIDE FRAGMENT; RITONAVIR; SAQUINAVIR; TIPRANAVIR; VASCULOTROPIN;

ACCESS TO INFORMATION; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; GENE THERAPY; GENOMICS; GONAD TUMOR; HEAD AND NECK TUMOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTERNET; LONG QT SYNDROME; MEDICAL RESEARCH; MODEL; MOLECULAR MODEL; MUTAGENESIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; QUANTUM THEORY; REVIEW; SICKLE CELL ANEMIA; STRUCTURAL BIOINFORMATICS; STRUCTURE ACTIVITY RELATION; X RAY DIFFRACTION;

EID: 65349160977     PISSN: 15748936     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489309787158170     Document Type: Review

References (242)

1. Chou KC. Review: Structural bioinformatics and its impact to biomedical science. Curr Med Chem 2004; 11: 2105-34.
2. Chou KC. Structural bioinformatics and its impact to biomedical science and drug discovery, In: Atta-ur-Rahman A, Reitz B Eds. Frontiers in Medicinal Chemistry. Bentham Science Publishers, The Netherlands, 2006; 3: 455-502.
3. Dong X, Ying X, Uberbacher EC. Computational tools for protein modelling. Curr Protein Pept Sci 2000; 1: 1-21.
4. Petry S, Brodersen DE, Murphy IV FV, et al. Crystal Structures of the Ribosome in Complex with Release Factors RF1 and RF2 Bound to a Cognate Stop Codon. Cell 2005; 123: 1255-66.
5. Bernhardt R. Cytochrome P450: structure, function, and generation of reactive oxygen species. Rev. Pysiol Pharmacol 1995; 127: 137-221.
6. Muller JJ, Lapko A, Bourenkov G, Ruckpaul K, Heinemann U. Adrenodoxin reductase-adrenodoxin complex structure suggests electron transfer path in steroid biosynthesis. J Biol Chem 2001; v276: 2786-89.
7. Müller A, Müller JJ, Muller YA, Uhlmann H, Bernhardt R, Heinemann U. New aspects of electron transfer revealed by the crystal structure of a truncated bovine adrenodoxin, Adx(4-108). Structure 1998; 6: 269-80.
8. Mc Donald NQ, Hendrickson WA. A structural super-family of growth factors containing a cystine knot motif. Cell 1993; 73: 421-24.
9. Suto K, Yamazaki Y, Morita T, Mizuno H. Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1. J Biol Chem 2005; 280: 2126-31.
10. Wells JA, de Vos AM. Hematopoitic receptor complexes. Annu Rev Biochem 1996; 65: 609-34.
11. Syed RS, Reid SW, Li C, et al, Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 1998; 395: 511-16.
12. Zhu X, Komiya H, Chirino A, et al. Three-dimensional structures of acidic and basic fibroblast growth factors. Science 1991; 251: 90-93.
13. Bernett MJ, Somasundaram T, Blaber M. An atomic resolution structure for human fibroblast growth factor 1. Proteins 2004; 57: 626-34.
14. Clore GM, Gronenborn AM. Three-dimensional structures of alpha and beta chemokines. FASEB J 1995; 9: 57-62.
15. Gerber N, Lowman H, Artis DR, Eigenbrot C. Receptor-binding conformation of the "ELR" motif of IL-8: X-ray structure of the L5C/H33C variant at 2.35 A resolution. Proteins 2000; 38: 361-67.
16. Thiel DJ, le Du MH, Walter RL, et al, Observation of an unexpected third receptor molecule in the crystal structure of human interferon-gamma receptor complex. Structure Fold Des 2000; 8: 927-36.
17. Cheung KH, Shineman D, Müller M, et al. Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating. Neuron 2008; 58(6): 871-83.
18. Coles B, Wilton LA, Good M, Chapman PF, Wann KT. Potassium channels in hippocampal neurones are absent in a transgenic but not in a chemical model of Alzheimer's disease. Brain Res 2008; 1190: 1-14.
19. Zhang X, Rueter JK, Chen Y, et al. Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonists. Bioorg Med Chem Lett 2008; 18(6): 1778-83.
20. Zeng J, Wang G, Chen SD. ATP-sensitive potassium channels: novel potential roles in Parkinson's disease. Neurosci Bull 2007; 23(6): 370-76.
21. Oyama F, Miyazaki H, Sakamoto N, et al. Sodium channel beta4 subunit: down-regulation and possible involvement in neuritic degeneration in Huntington's disease transgenic mice. J Neurochem 2006; 98(2): 518-29.
22. Scatena R, Martorana GE, Bottoni P, Botta G, Pastore P, Giardina B. An update on pharmacological approaches to neurodegenerative diseases. Expert Opin Investig Drugs 2007; 16(1): 59-72.
23. Ren G, Reddy VS, Cheng A, Melnyk P, Mitra AK. Visualization of a water-selective pore by electron crystallography in vitreous ice. Proc Natl Acad Sci USA 2001; v98: 1398-1403.
24. Kendrew JC, Dickerson RE, Strandberg BE, et al. Structure of myoglobin. A three- dimensional Fourier sythesis at 2 angstrom resolution. Nature 1960; 185: 422-27.
25. Perutz MF, Muirhead H, Cox JM, Goaman LC. Three-dimensional Fourier synthesis of horse oxyhaemoglobin at 2.8 angstrom resolution: the atomic model. Nature 1968; 219: 131-39.
26. De la Fortelle E, Bricogne G. Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. Methods Enzymol 1997; 276: 472-94.
27. Perrakis A, Morris R, Lamzin VS. Automated protein model building combined with iterative structure refinement Nat Struct Biol 1999; 6: 458-63.
28. Terwilliger TC, Berendzen J. Automated structure solution for MIR and MAD. Acta Crystallogr D 1999; 55: 849-61.
29. Weeks CM, Miller R. Optimizing shake-and-bake for proteins. Acta Crystallogr D 1999; 55: 492-500.
30. Kleywegt GJ, Harris MR, Zou JY, Taylor TC, Wählby A, Jones TA. "The Uppsala Electron-Density Server". Acta Cryst 2004; D60: 2240-49.
31. Murzin AG, Brenner SE, Hubbard T, Chothia C. SCOP: a structural classification of proteins database fort he investigation of sequences and structures. J Mol Biol 1995; 247: 536-40.
32. Andreeva A, Howorth D, Chandonia JM, et al. Data growth and its impact on the SCOP database: new developments. Nucl Acid Res 2008; 36: 419-25.
33. Berman HM, Westbrook J, Feng Z, et al. The Protein Data Bank. Nucleic Acids Res 2000; 28: 235-42.
34. Baxevanis AD. Searching the NCBI databases using Entrez. Curr Protoc Hum Genet 2006; Chapter 6: Unit 6.10.
35. Falkner JA, Hill JA, Andrews PC. Proteomics FASTA archive and reference resource. Proteomics 2008; 8(9): 1756-57.
36. Sussman JL, Abola EE, Lin D, Jiang J, Manning NO, Prilusky J. The protein data bank. Bridging the gap between the sequence and 3D structure world. Genetica 1999; 106(1-2): 149-58.
37. Sussman JL, Lin D, Jiang J, et al. Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules. Acta Crystallogr D Biol Crystallogr 1998; 54(Pt 6 Pt 1): 1078-84.
38. Westbrook JD, Fitzgerald PM. The PDB format, mmCIF, and other data formats. Methods Biochem Anal 2003; 44: 161-79.
39. McCray AT, Divita G. ASN.1: defining a grammar for the UMLS knowledge sources. Proc Annu Symp Comput Appl Med Care 1995; 868-72.
40. Levinthal C, Barry CD. Computer Graphics in Macromolecular Chemistry, In: Secrest D, Nievergelt J Eds. Emerging Concepts in Computer Graphics. W. A. Benjamin, NY 1968; 231-53.
41. Johnson CK. "OR TEP: A FORTRAN Thermal-Ellipsoid Plot Program for Crystal Structure Illustrations". ONRL Report #3794. Oak Ridge National Laboratory, Oak Ridge, Ten, 1968.
42. Beem KM, Richardson DC, Rajagopalan KV. Metal sites of copper-zinc superoxide dismutase. Biochemistry 1977; 16(9): 1930-36.
43. Ricardson DC, Richardson JS. Kinemages - Simple macromolecular graphics for interactive teaching and publication. Trends Biochem Sci 1994; 19: 135-38.
44. Sayle RA, Milner-White EJ. RASMOL: Biomolecular graphics for all. Trends Biochem Sci 1995; 20: 374.
45. Hogue CW. Cn3D: A new generation of three-dimensional molecular structure viewer. Trends Biochem Sci 1997; 22: 314-16.
46. Wang Y, Geer LY, Chappey C, Kans JA, Bryant SH. Cn3D: sequence and structure views for Entrez. Trends Biochem Sci 2000; 5(6): 300-02.
47. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-Pdb Viewer: An environment for comparative protein modelling. Electrophoresis 1997; 18: 2714-23.
48. Walther D. WebMol- a Java based PDB viewer. Trends Biochem Sci 1997; 22: 274-75.
49. Davis IW, Murray LW, Richardson JS, Richardson DC. MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Res 2004; 1: 32.
50. Lancashire RJ. The JSpecView Project: an Open Source Java viewer and converter for JCAMP-DX and XML spectral data files. Chem Cent J 2007; 1:31.
51. Watanabe K, Yasukawa K, Iso K. Graphic display of nucleic acid structure by a microcomputer. Nucleic Acids Re 1984; 12: 801-09.
52. Bowen JP, Charifson PS, Fox PC, et al. Computer-assisted molecular modeling: indispensable tools for molecular pharmacology. J Clin Pharmacol 1993; 33(12): 1149-64.
53. Smith TJ. MolView: a program for analyzing and displaying atomic structures on the Macintosh personal computer. J Mol Graph 1995; 13(2): 122-25.
54. Hannon GJ, Jentoft JE. MOLECULAR DESIGNER: an interactive program for the display of protein structure on the IBM-PC. Comput Appl Biosci 1985; 1(3): 177-81.
55. Light WR, Gaber BP. NanoVision-molecular graphics for the Macintosh. J Mol Graph 1994; 12(3): 172-77.
56. Merritt EA, Murphy ME. Raster3D Version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr D Biol Crystallog 1994; 50:869-73.
57. Crivelli S, Kreylos O, Hamann B, Max N, Bethel W. ProteinShop: a tool for interactive protein manipulation and steering. J Comput Aided Mol De 2004; 18(4): 271-85.
58. Gabdoulline RR, Hoffmann R, Leitner F, Wade RC. ProSAT: functional annotation of protein 3D structures. Bioinformatics 2003; 19(13): 1723-25.
59. Gabdoulline RR, Ulbrich S, Richter S, Wade RC. ProSAT2 - Protein Structure Annotation Server. Nucleic Acids Res 2006; 34: 79-83.
60. Wiltgen M, Holzinger A. Visualization in Bioinformatics: Protein Structures with Physicochemical and Biological Annotations, In: Zara J, Sloup J Eds. Central European Multimedia and Virtual Reality Conference. CEMVRC, 2005; 69-74.
61. Huang W, Matte A, Li Y, et al. Crystal structure of chondroitinase B from Flavobacterium heparinum and its complex with a disaccharide product at 1.7 A resolution. J Mol Biol 1999; 294: 1257-69.
62. Lee B, Richards FM. The interpretation of protein structures: Estimation of static accessibility. J Mo Biol 1971; 55: 379-400.
63. Eisenberg D, Mc Lachlan AD. Solvation energy in protein folding and binding. Nature 1986; 319: 199-203.
64. Richards FM. Areas, volumes, packing, and protein structure. Annu Rev Biophys Bioeng 1997; 6: 151-76.
65. Neshich G, Rocchia W, Mancini AL, et al. Java Protein Dossier: a novel web-based data visualization tool for comprehensive analysis of protein structures. Nucleic Acids Res 2004; 32: 595-601.
66. Golovin A, Oldfield TJ, Tate JG et al. E-MSD: an integrated data resource for bioinformatics. Nucleic Acids Res 2004; 32: 211-16.
67. Leslin CM, Abyzov A, Ilyin VA. Structural exon database, SEDB, mapping exon boundaries on multiple protein structures. Bioinformatics 2004; 20(11): 1801-03.
68. Oldfield TJ. A Java applet for multiple linked visualization of protein structure and sequence. J Comput Aided Mol De 2004; 18(4): 225-34.
69. Vivek G, Tan TW, Ranganathan S. XdomView: protein domain and exon position visualization. Bioinformatics 2003; 19(1): 159-60.
70. Ilyin VA, Pieber U, Stuart AC, Marti-Renom MA, MCMahan L, Sali A. ModView, visualization of multiple protein sequences and structures. Bioinformatics 2003; 19(1):165-66.
71. Catherinot V, Labesse G. ViTO: tool for refinement of protein sequence-structure alignments. Bioinformatics 2004; 20(18): 3694-96.
72. Zhang J, Rowe WL, Struewing JP, Buetow KH. Hapscope: a software system for automated and visual analysis of functionally annotated haplotypes. Nucleic Acids Res 2002; 30(23): 5213-21.
73. Bjellqvist B, Hughes GJ, Pasquali C, et al. The focusing positions of polypeptides in immobilized pH gradients can be predicted from their amino acid sequences. Electrophoresis 1993; 14: 1023-31.
74. Bachmair A, Finley D, Varshavsky A. In vivo half-life of a protein is a function of its amino-terminal residue. Science 1986; 234: 179-86.
75. Guruprasad K, Reddy BV, Pandit MW. Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence. Protein Eng 1990; 4: 155-61.
76. Kyte J, Doolitle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982; 157: 105-32.
77. Rost B. PHD: predicting one-dimensional protein structure by profile based neural networks. Methods in Enzymology 1996; 266: 525-39.
78. Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 2003; 31: 3784-88.
79. Bairoch A, Apweiler R. The SWISS-PROT protein sequence databank and its supplement TrEMBL in 1998. Nucl Acids Res 1998; 26: 38-42.
80. Attwood TK, Avison H, Beck ME, et al. The PRINTS database of protein fingerprints: a novel information resource for computational molecular biology. J Chem Inform Comput Sci 1997; 37(3): 417-24.
81. Attwood TK, Croning MDR, Flower DR, et al. PRINTS-S: the database formerly known as PRINTS. Nucleic Acids Res 2000; 28: 225-27.
82. Bateman A, Birney E, Durbin R, Eddy SR, Howe KL, Sonnhammer EL. The Pfam protein families database. Nucleic Acids Res 2000; 28: 263-66.
83. Sammut SJ, Finn RD, Bateman A. Pfam 10 years on: 10,000 families and still growing. Brief Bioinform 2008; 9(3): 210-19.
84. Marchler-Bauer A, Panchenko AR, Shoemaker BA, et al. CDD: a database of conserved domain alignments with links to domain three-dimensional structure. Nucleic Acids Res 2002; 30: 281-83.
85. Marchler-Bauer A, Anderson JB, Derbyshire MK, et al. CDD: a conserved domain database for interactive domain family analysis. Nucleic Acids Res 2007; 35: 237-40.
86. Henikoff S, Henikoff JG. Automated assembly of protein blocks for database searching. Nucleic Acids Res 1991; 19: 6565-72.
87. Henikoff S, Henikoff JG, Pietrokovski S. Blocks+: A non-redundant database of protein alignment blocks derived from multiple compilations. Bioinformatics 1999; 15: 471-79.
88. Hulo N, Bairoch A, Bulliard V, et al. The 20 years of PROSITE. Nucleic Acids Res 2008; 36: 245-49.
89. Henschel A, Winter C, Kim WK, Schroeder M. Using structural motif descriptors for sequence-based binding site prediction. BMC Bioinformatics 2007; 8(Suppl 4): 5.
90. Bucher P, Bairoch A. A generalized profile syntax for biomolecular sequences motifs and its function in automatic sequence interpretation, In: Altman R, Brutlag D, Karp P, Lathrop R, Searls D Eds. ISMB-94; Proceedings 2nd International Conference on Intelligent Systems for Molecular Biology. AAAIPress, Menlo Park 1994; 53-61.
91. Haefliger DN, Moskaitis JE, Schoenberg DR, Wahli W. Amphibian albumins as members of the albumin, alpha-fetoprotein, vitamin D-binding protein multigene family. J Mol Evol 1989; 29: 344-54.
92. Schoentgen F, Metz-Boutigue M. -H, Jolles J, Constans J, Jolles P. Complete amino acid sequence of human vitamin D-binding protein (group-specific component): evidence of a three-fold internal homology as in serum albumin and alpha-fetoprotein. Biochim Biophys Actan 1986; 871: 189-98.
93. Lichenstein HS, Lyons DE, Wurfel MM, et al. Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin D-binding protein gene family. J Biol Chem 1994; 269: 18149-54.
94. Lejon S, Frick IM, Bjorck L, Wikstrom M, Svensson S. Crystal structure and biological implications of a bacterial albumin binding module in complex with human serum albumin. J Biol Chem 2004; 279: 42924-28.
95. Chou KC, Shen HB. MemType-2L: A Web server for predicting membrane proteins and their types by incorporating evolution information through Pse-PSSM. Biochem Biophys Res Comm 2007; 360: 339-45.
96. Chou KC, Shen HB. Signal-CF: a subsite-coupled and window-fusing approach for predicting signal peptides. Biochem Biophys Res Comm 2007; 357: 633-40.
97. Shen HB, Chou KC. Signal-3L: a 3-layer approach for predicting signal peptide. Biochem Biophys Res Comm 2007; 363: 297-303.
98. Vorderwülbecke S, Cleverley S, Weinberger SR, Wiesner A. Protein quantification by the SELDI-TOF-MS-based ProteinChip System. Nature Methods 2005; 2,5: 393-95.
99. Zenobi R, Knochenmuss R. Ion formation in maldi mass spectrometry. Mass Spectrom Rev 1998; 17: 337-66.
100. Karas M, Glückmann M, Schäfer J. Ionization in matrix-assisted desorption/ionization: singly charged molecular ions are the lucky survivors. J Mass Spectrom 2000; 35: 1-12.
101. Gasteiger E, Hoogland C, Gattiker A, et al. Protein Identification and Analysis Tools on the ExPASy Server, In: Walker JM Eds. The Proteomics Protocols Handbook. Humana Press, 2005; 571-607.
102. Tuloup M, Hernandez C, Coro I, Hoogland C, Binz P-A, Appel RD. Aldente and BioGraph: An improved peptide mass fingerprinting protein identification environment, In: Understanding Biological Systems through Proteomics. Fontis Media, Basel, Switzerland, 2003; 174-76.
103. Xu D, Xu Y, Uberbacher EC. Computational Tools for Protein Modeling. Curr Protein Pept Sci 2000; 1: 1-21.
104. Johnson MS, Srinivasan N, Sowdhamini R, Blundell TL. Knowledge-based proteinmodelling. CRC Crit Rev Biochem Mol Biol 1994; 29: 1-68.
105. Sanchez R, Sali A. Comparative protein structure modeling. Introduction and practical examples with modeller. Methods Mol Biol 2000; 143: 97-129.
106. Sanchez R, Sali A. Advances in comparative protein-structure modelling. Curr Opin Struct Biol 1997; 7: 206-14.
107. Schwede T, Diemand A, Guex N, Peitsch MC. Protein structure computing in the genomic era. Res Microbiol 2000; 151: 107-12.
108. Fiser A, Sanchez R, Melo F, Sali A. Comparative protein structure modelling. In. Watanabe M, Roux B, MacKerell AD Jr., Becker O Eds, Computational Biochemistry and Biophysics. Marcel Dekker, 2001; 275-312.
109. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993; 234: 779-815.
110. Fiser A, Kinh G, Do R, Sali A. Modeling of loops in protein structures. Protein Sci 2000; 9: 1753-73.
111. Peitsch MC. Protein modelling by E-Mail. Bio Technol 1995; 13: 658-60.
112. Peitsch MC. ProMod and Swiss-Model: Internet-based tools for automated comparative protein modelling. Biochem Soc Tran 1996; 24: 274-79.
113. Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006; 22 2: 195-201.
114. Schwede T, Kopp J, Guex N, Peitsch M.C. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Research 2003; 231(13): 3381-85.
115. Eswar N, Eramian D, Webb B, Shen MY, Sali A. Protein structure modelling with MODELLER. Methods Mol Biol 2008; 426: 145-59.
116. Eswar N, Webb B, Marti-Renom MA, et al. Comparative protein structure modeling using MODELLER. Curr Protoc Protein Sci 2007; Chapter 2: Unit 2.9.
117. Read JA, Winter VJ, Eszes CM, Sessions RB, Brad RL. Structural basis for altered activity of M- and H-isozyme forms of human lactate dehydrogenase. Proteins 2001; 43: 175-85.
118. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. "Basic local aligment search tool". J Mol Biol 1990; 215: 403-10.
119. White JL, Hackert ML, Buehner M, et al. A comparison of the structures of apo dogfish M4 lactate dehydrogenase and its ternary complexes. J Mol Biol 1997; 102: 759-79.
120. Hogrefe HH, Griffith JP, Rossmann MG, Goldberg E. Characterization of the antigenic sites on the refined 3-A resolution structure of mouse testicular lactate dehydrogenase C4. J Biol Chem 1987; 262: 13155-62.
121. Grau UM, Trommer WE, Rossmann MG. Structure of the active ternary complex of pig heart lactate dehydrogenase with S-lac-NAD at 2.7 A resolution. J Mol Biol 1981; 151: 289-307.
122. Laskowski R A, MacArthur M W, Moss D S, Thornton J M. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 1993; 26: 283-91.
123. Adane L, Bharatam PV. Modelling and informatics in the analysis of P. falciparum DHFR enzyme inhibitors. Curr Med Chem 2008; 15(16): 1552-69.
124. Lambert JM, Siezen RJ, de Vos WM, Kleerebezem M. Improved annotation of conjugated bile acid hydrolase superfamily members in Gram-positive bacteria. Microbiology 2008; 154(8): 2492-2500.
125. Rocher A, Marchand-Geneste N. Homology modelling of the Apis mellifera nicotinic acetylcholine receptor (nAChR) and docking of imidacloprid and fipronil insecticides and their metabolites. SAR QSAR Environ Res 2008; 19(3-4): 245-61.
126. Hou S, Li B, Wang L, et al. Humanization of an Anti-CD34 Monoclonal Antibody by Complementarity-determining Region Grafting Based on Computer-assisted Molecular Modelling. J Biochem 2008; 144(1): 115-20.
127. Sgobba M, Degliesposti G, Ferrari AM, Rastelli G. Structural models and binding site prediction of the C-terminal domain of human Hsp90: a new target for anticancer drugs. Chem Biol Drug Des 2008; 71(5): 420-33.
128. Capitani G, De Biase D, Gut H, Ahmed A, Grutter MG. Structural Model of Human GAD65: Prediction and Interpretation of Biochemical and Immunogenic Features. Proteins: Struct Funct Bioinform 2005; 59: 7-14.
129. Wiltgen M, Tilz GP. A Basic Molecular analysis of the diabetic antigen Gad by Homology Modelling. Principles of the Method and understanding of Antigenicity and binding sites. Pteridines 2007; 18: 79-94.
130. Guvench O, MacKerell AD Jr. Comparison of protein force fields for molecular dynamics simulations. Methods Mol Biol 2008; 443: 63-88.
131. Li Z, Yu H, Zhuang W, Mukamel S. Geometry and Excitation Energy Fluctuations of NMA in Aqueous Solution with CHARMM, AMBER, OPLS, and GROMOS Force Fields: Implications for Protein Ultraviolet Spectra Simulation. Chem Phys Lett 2008; 452(1-3): 78-83.
132. Komáromi I, Owen MC, Murphy RF, Lovas S. Development of glycyl radical parameters for the OPLS-AA/L force field. J Comput Chem 2008; 29(12): 1999-2009.
133. Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 2006; 65(3): 712-25.
134. Christen M, Hünenberger PH, Bakowies D, et al. The GROMOS software for biomolecular simulation: GROMOS05. J Comput Chem 2005; 26(16): 1719-51.
135. Price DJ, Brooks CL. Modern protein force fields behave comparably in molecular dynamics simulations. J Comput Chem 2002; 23(11): 1045-57.
136. Xu Z, Luo HH, Tieleman DP. Modifying the OPLS-AA force field to improve hydration free energies for several amino acid side chains using new atomic charges and an off-plane charge model for aromatic residues. J Comput Chem 2007; 28(3): 689-97.
137. Gibrat JF, Madej T, Bryant SH. Surprising similarities in structure comparison. Curr Opin Struct Biol 1996; 6(3): 377-85.
138. Bacon DJ, Moult J. Docking by least-squares fitting of molecular surface patterns. J Mol Biol 1992; 225: 849-58.
139. Chau PL, Dean PM. Molecular recognition: 3D surface structure comparision by gnomonic projection. J Mol Graphics 1987; 5: 97-100.
140. Uetz P, Giot L, Cagney G, et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 2000; 403: 623-27.
141. Duncan B, Olson AJ. Shape analysis of molecular surface. Biopolymers 1993; 33: 231-38.
142. Duncan B, Olson AJ. Approximation and characterization of molecular surfaces. Biopolymers 1993; 33: 219-29.
143. Gabdoulline RR, Wade RC. Analytically defined surfaces to analyze molecular interaction properties. J Mol Graph 1996;14(6): 341-53, 374-75.
144. Voronoi G. Recherche sur les paralleloedres primitifs. J Reine Angw Math 1908; 134: 198-287.
145. Sadoc JF, Jullien R, Rivier N. The Laguerre polyhedral decomposition: application to protein folds. Eur Phys J B 2003; 33: 355-63.
146. Dupuis F, Sadoc JF, Mornon JP. Protein Secondary Structure Assignment Through Voronoi Tessellation. Proteins: Struct Funct Bioinform 2004; 55: 519-28.
147. Angelov B, Sadoc JF, Jullien R, Soyer A, Mornon JP, Chomilier J. Nonatomic Solvent-Driven Voronoi Tessellation of Proteins: A Open Tool to Analyze Protein Folds. Proteins: Struct Funct Genet 2002; 49: 446-56.
148. Dupuis F, Sadoc JF, Jullien R, Angelov B, Mornon JP. Voro3D: 3D voronoi tessellations applied to protein structures. Bioinformatics 2005; 21(8): 1715-16.
149. Finn RD, Marshall M, Bateman A. iPfam: visualization of protein-protein interactions in PDB at domain and amino acid resolutions. Bioinformatics 2005; 21(3): 410-12.
150. Gabdoulline RR, Wade RC, Walther D. MolSurfer: A macromolecular interface navigator. Nucleid Acids Res 2003; 31(13): 3349-51.
151. Wiltgen M, Holzinger A, Tilz GP. Interactive Analysis and Visualization of Macromolecular Interfaces between Proteins. Lecture Notes in Computer Sciences 2007; 4799: 199-212.
152. Wiltgen M, Tilz GP. Tumour necrosis factor and its receptor: a basic structural analysis of two counterparts. Hematology 2008; 13,4: 224-29.
153. Jayapal P, Sundararajan M, Hillier IH, Burton NA. QM/MM studies of Ni-Fe hydrogenases: the effect of enzyme environment on the structure and energies of the inactive and active states. Phys Chem Chem Phys 2008; 10(29): 4249-57.
154. Perruccio F, Ridder L, Mulholland AJ. Quantum-mechanical/ Molecular-mechanical Methods in Medicinal Chemistry, In: Carloni P, Alber F Eds, Quantum Medicinal Chemistry. WILEY_VCH Verlag GmbH&Co. Weinheim 2003.
155. Jensen F. Introduction to computational chemistry. John Wiley&Sons Ltd, UK 2007.
156. Reinhold J. Quantentheorie der Moleküle. B.G. Teubner Verlag, Wiesbaden 2004.
157. Hinchliffe A. Molecular modelling for beginners. John Wiley&Sons Ltd UK 2003.
158. Szabo A, Ostlund NS. Modern quantum chemistry. Dover Publications, INC, Mineola, New York 1996.
159. Cavalli A, Folkers G, Recanatini M, Scapozza L. Density-functional theory applications in computational medicinal chemistry, In: Carloni P, Alber F Eds, Quantum Medicinal Chemistry. WILEY_VCH Verlag GmbH&Co, Weinheim 2003.
160. Raber J, Liano J, Eriksson LA. Density-functional theory in drug design - the chemistry of the anti-tumour drug cisplatin and photoactive psoralen compounds. In: Carloni P, Alber F. (eds) Quantum Medicinal Chemistry WILEY_VCH Verlag GmbH&Co, Weinheim 2003.
161. Várnai P, Richards WG, Lyne PD. Modelling the catalytic reaction in human aldose reductase. Proteins 1999; 37(2): 218-27.
162. Ridder L, Rietjens IM, Vervoort J, Mulholland AJ. Quantum mechanical/ molecular mechanical free energy simulations of the glutathione S-transferase (M1-1) reaction with phenanthrene 9,10-oxide. J Am Chem Soc 2002; 124(33): 9926-36.
163. Mlinsek G, Novic M, Hodoscek M, Solmajer T. Prediction of enzyme binding: human thrombin inhibition study by quantum chemical and artificial intelligence methods based on X-ray structures. J Chem Inf Comput Sci 2001; 41(5): 1286-94.
164. Dinner AR, Blackburn GM, Karplus M. Uracil-DNA glycosylase acts by substrate autocatalysis. Nature 2001; 413(6857): 752-5.
165. Sulpizi M, Schelling P, Folkers G, Carloni P, Scapozza L. The rational of catalytic activity of herpes simplex virus thymidine kinase a combined biochemical and quantum chemical study. J Biol Chem 2001; 276(24): 21692-7.
166. Alhambra C, Sanchez ML, Corchado JC, et al. Quantum mechanical tunneling in methylamine dehydrogenase. Chemi Phys Lett 2002; 355: 388-94.
167. Alhambra C, Corchado J, Sanchez ML, et al. Canonical variational theory for enzyme kinetics with the protein mean force and multi-dimensional quantum mechanical tunneling dynamics. Theory and application to liver alcohol dehydrogenase. J Phys Chem B 2001; 105(45): 11326-40.
168. Alhambra C, Corchado JC, Sanchez ML, et al.Quantum dynamics of hydride transfer in enzyme catalysis. J Am Chem Soc 2000; 122(34): 8197-203.
169. Alhambra C, Gao JL, Corchado JC, et al. Quantum mechanical dynamical effects in an enzyme-catalyzed proton transfer reaction. J Am Chem Soc 1999; 121(10): 2253-58.
170. Chang PL. Clinical bioinformatics. Gung Med. 2005; 28(4): 201-11.
171. Snow CD. Hunting for predictive computational drug-discovery models. Expert Rev Anti Infect Ther 2008; 6(3): 291-93.
172. Wishart DS. Identifying putative drug targets and potential drug leads: starting points for virtual screening and docking. Methods Mol Biol 2008; 443: 333-51.
173. Chen YP, Chen F. Identifying targets for drug discovery using bioinformatics. Expert Opin Ther Targets 2008; 12(4): 383-89.
174. Bharatam PV, Patel DS, Adane L, Mittal A, Sundriyal S. Modeling and informatics in designing anti-diabetic agents. Curr Pharm Des 2007; 13(34): 3518-30.
175. Rainsford KD. Anti-inflammatory drugs in the 21st century. Subcell Biochem 2007; 42: 3-27.
176. Kopecny D, Sebela M, Briozzo P, et al. Mechanism-based inhibitors of cytokinin oxidase/dehydrogenase attack FAD cofactor. J Mol Biol 2008; 380: 886-99.
177. Hamera-Słynarska M, Słynarski K. The undesirable side-effects of non-steroidal anti-inflammatory drugs. Ortop Traumatol Rehabil 2001; 3(1): 126-28.
178. Salinas G, Rangasetty UC, Uretsky BF, Birnbaum Y. The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame. J Cardiovasc Pharmacol Ther 2007; 12(2): 98-111.
179. Reddy RN, Mutyala R, Aparoy P, Reddanna P, Reddy MR. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs. Curr Pharm Des 2007; 13(34): 3505-17.
180. Rajakrishnan V, Manoj VR, Subba Rao G. Computer-aided, rational design of a potent and selective small peptide inhibitor of cyclooxygenase 2 (COX2). J Biomol Struct Dyn 2008; 25(5): 535-42.
181. Chou KC, Watenpaugh KD, Heinrikson RL. A Model of the complex between cyclin- dependent kinase 5(Cdk5) and the activation domain of neuronal Cdk5 activator. Biochem Biophys Res Commun 1999; 259: 420-28.
182. Chou KC, Howe WJ. Prediction of the tertiary structure of the beta-secretase zymogen. BBRC 2002; 292: 702-08.
183. Chou KC. Insights from modelling the tertiary structure of BACE2. J Proteome Res 2004; 3; 1069-72.
184. Chou KC. Modeling the tertiary structure of human cathepsin-E. Biochem Biophys Res Commun 2005; 331: 56-60.
185. Wei DQ, Sirois S, Du QS, Arias HR, Chou KC. Theoretical studies of Alzheimer's disease drug candidate [(2,4-dimethoxy) benzylidene]-anabaseine dihydrochloride (GTS-21) and its derivatives. BBRC 2005; 338: 1059-64.
186. Chou KC. Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. Biochem Biophys Res Commun 2004; 316: 636-42.
187. Chou KC. Insights from modelling the 3D structure of the extracellular domain of alpha7 nicotinic acetylcholine receptor. Biochemical and Biophysical Research Communication 2004; 319: 433-38.
188. Chou KC, Wei DQ, Zhong WZ. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. (Erratum: ibid., 2003, Vol.310, 675). Biochem Biophys Res Comm 2003; 308: 148-51.
189. Zhang R, Wei DQ, Du QS, Chou KC. Molecular modeling studies of peptide drug candidates against SARS. Med Chem 2006; 2: 309-14.
190. Chou KC. Molecular therapeutic target for type-2 diabetes. J Proteome Res 2004; 3: 1284-88.
191. Chou KC. Insights from modelling three-dimensional structures of the human potassium and sodium channels. J Proteome Res 2004; 3: 856-61.
192. Gao WN, Wei DQ, Li Y, et al. Agaritine and its derivatives are potential inhibitors against HIV proteases. Med Chem 2007; 3: 221-26.
193. Wang SQ, Du QS, Chou KC. Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases. Biochem Biophys Res Comm 2007; 354: 634-40.
194. Du QS, Wang SQ, Chou KC. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus. Biochem Biophys Res Comm 2007; 362: 525-31.
195. Chou KC, Jones D, Heinrikson RL. Prediction of the tertiary structure and substrate binding site of caspase-8. FEBS Lett 1997; 419: 49-54.
196. Chou KC, Tomasselli AG. Heinrikson RL. Prediction of the Tertiary Structure of a Caspase-9/Inhibitor Complex. FEBS Lett 2000; 470: 249-56.
197. Wei H, Zhang R, Wang C, Zheng H, Chou KC, Wei DQ. Molecular insights of SAH enzyme catalysis and their implication for inhibitor design. J Theor Biol 2007; 244: 692-702.
198. Wang JF, Wei DQ, Li L, Zheng SY, Li YX, Chou KC. 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design. Biochem Biophys Res Commun (Corrigendum: ibid, 2007, vol. 357, 330). 2007; 355, 513-19.
199. Wang JF, Wei DQ, Chen C, Li Y, Chou KC. Molecular modeling of two CYP2C19 SNPs and its implications for personalized drug design. Protein Pept Lett 2008; 15: 27-32.
200. Chou KC, Shen HB. Cell-PLoc: A package of web-servers for predicting subcellular localization of proteins in various organisms. Nat Protoc 2008; 3: 153-62.
201. Raha K, Peters MB, Wang B, et al. The role of quantum mechanics in structure-based drug design. Drug Discov Today 2007; 12(17-18): 725-31.
202. Spiegel K, Magistrato A. Modeling anticancer drug-DNA interactions via mixed QM/MM molecular dynamics simulations. Org Biomol Chem 2006; 4(13): 2507-17.
203. Reddy MR, Singh UC, Erion MD. Ab initio quantum mechanics-based free energy perturbation method for calculating relative solvation free energies. J Comput Chem 2007; 28(2): 491-94.
204. Spiegel K, Magistrato A. Modeling anticancer drug-DNA interactions via mixed QM/MM molecular dynamics simulations. Org Biomol Chem 2006; 4(13): 2507-17.
205. Hammer SM, Eron JJ Jr, Reiss P, et al. International AIDS Society-USA. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 2008; 300(5): 555-70.
206. Tucker TJ, Saggar S, Sisko JT, et al. The design and synthesis of diaryl ether second generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) with enhanced potency versus key clinical mutations. Bioorg Med Chem Lett 2008; 18: 2959-66.
207. Liu F, Kovalevsky AY, Tie Y, Ghosh AK, Harrison RW, Weber IT. Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir. J Mol Biol 2008; 381: 102-15.
208. Pawiński T, Pulik P, Gralak B, Horban A. Pharmacokinetic monitoring of HIV-1 protease inhibitors in the antiretroviral therapy. Acta Pol Pharm 2008; 65(1): 93-100.
209. Nair V, Chi G. HIV integrase inhibitors as therapeutic agents in AIDS. Rev Med Virol 2007; 17(4): 277-95.
210. Sherman W, Tidor B. Novel method for probing the specificity binding profile of ligands: applications to HIV protease. Chem Biol Drug Des 2008;71(5): 387-407.
211. Almerico AM, Tutone M, Lauria A. Docking and multivariate methods to explore HIV-1 drug-resistance: a comparative analysis. J Comput Aided Mol Des 2008; 22(5): 287-97.
212. Saen-oon S, Aruksakunwong O, Wittayanarakul K, Sompornpisut P, Hannongbua S. Insight into analysis of interactions of saquinavir with HIV-1 protease in comparison between the wild-type and G48V and G48V/ L90M mutants based on QM and QM/MM calculations. J Mol Graph Model 2007; 26(4): 720-27.
213. Brunori M, Bourgeois D, Vallone B. Structural dynamics of myoglobin. Methods Enzymol 2008; 437: 397-416.
214. Rovira C, Schulze B, Eichinger M, Evanseck JD, Parrinello M. Influence of the heme pocket conformation on the structure and vibrations of the Fe-CO bond in myoglobin: a QM/MM density functional study. Biophys J 2001; 81(1): 435-45.
215. Strickland N, Mulholland AJ, Harvey JN. The Fe-CO bond energy in myoglobin: a QM/MM study of the effect of tertiary structure. Biophys J 2006; 90(4): 27-29.
216. Capece L, Marti MA, Crespo A, Doctorovich F, Estrin DA. Heme protein oxygen affinity regulation exerted by proximal effects. J Am Chem Soc 2006; 128(38): 12455-61.
217. Riera AR, Uchida AH, Ferreira C, et al. Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome. Cardiol J 2008; 15(3): 209-19.
218. Fazio G, Pipitone S, D'Angelo L, et al. The long QT syndrome in pediatric age: prognosis and risk factor. Minerva Cardioangiol 2008; 56(4): 387-90.
219. Yang WP, Levesque PC, Little WA, Conder ML, Shalaby FY, Blanar MA. KvLQTI, a voltage-gated potassium channel responsible for human cardiac arrhythmias. Proc Natl Acad Sci U.S.A 1997; 94: 4017-21.
220. Sugie M, Ishihara K, Simizu Y, Oono H, Kawamura M. Case report of transient splenium abnormality in Charcot-Marie-Tooth disease. Rinsho Shinkeigaku 2008; 48(5): 359-62.
221. Jackson CE. A clinical approach to muscle diseases. Semin Neurol 2008; 28(2): 228-40.
222. Walke VA, Walde MS. Haematological study in sickle cell homozygous and heterozygous children in the age group 0-6 years. Indian J Pathol Microbiol 2007; 50(4): 901-04.
223. Lebensburger J, Persons DA. Progress toward safe and effective gene therapy for beta- thalassemia and sickle cell disease. Curr Opin Drug Discov Devel 2008; 11(2): 225-32.
224. Zhu C, Raber J, Eriksson LA. Hydrolysis process of the second generation platinum-based anticancer drug cis-amminedichlorocyclohexylamineplatinum(II). J Phys Chem B 2005; 109(24): 12195-205.
225. Raber J, Zhu C, Eriksson LA. Theoretical study of cisplatin binding to DNA: the importance of initial complex stabilization. J Phys Chem B 2005; 109(21): 11006-15.
226. Coste F, Malinge JM, Serre L, et al. Crystal structure of a double-stranded DNA containing a cisplatin interstrand cross-link at 1.63 A resolution: hydration at the platinated site. Nucleic Acids Res 1999; 27(8): 1837-46.
227. Huang H, Zhu L, Reid BR, Drobny GP, Hopkins PB. Solution structure of a cisplatin-induced DNA interstrand cross-link. Science 1995; 270(5243): 1842-45.
228. Thal DR, Griffin WS, de Vos RA, Ghebremedhin E. Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathol 2008; 115(6): 599-609.
229. Urosevic N, Martins RN. Infection and Alzheimer's disease: the APOE epsilon4 connection and lipid metabolism. J Alzheimers Dis 2008; 13(4): 421-35.
230. Zappasodi F, Salustri C, Babiloni C, et al. An observational study on the influence of the APOE-epsilon4 allele on the correlation between 'free' copper toxicosis and EEG activity in Alzheimer disease. Brain Res 2008; 1215: 183-89.
231. van der Flier WM, Pijnenburg YA, Schoonenboom SN, Dik MG, Blankenstein MA, Scheltens P. Distribution of APOE genotypes in a memory clinic cohort. Dement Geriatr Cogn Disord 2008; 25(5): 433-38
232. Raber J. AR, apoE, and cognitive function. Horm Behav 2008; 53(5): 706-15.
233. Xiong YM, Haas TA, Zhang L. Identification of functional segments within the beta2I-domain of integrin alphaMbeta2. J Biol Chem 2002; 277(48): 46639-44.
234. Li Y, Lawrence DA, Zhang L. Sequences within domain II of the urokinase receptor critical for differential ligand recognition. J Biol Chem 2003; 278(32): 29925-32.
235. Pál G, Fong SY, Kossiakoff AA, Sidhu SS. Alternative views of functional protein binding epitopes obtained by combinatorial shotgun scanning mutagenesis. Protein Sci 2005; 14(9): 2405-13.
236. Baekkeskov S, Landin M, Kristensen JK, et al. Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest 1987; 79(3): 926-34.
237. Myers MA, Fenalti G, Gray R, et al. A major diabetes-related conformational epitope on GAD65. Ann NY Acad Sci 2003; 1005: 250-52.
238. Schwartz HL, Chandonia JM, Kash SF, et al. High-resolution autoreactive epitope mapping and structural modelling of the 65 kDa form of glutamic acid Decarboxylase. J Mol Biol 1999; 287: 983-99.
239. Fenalti G, Law RH, Buckle AM, et al. GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop. Struct Mol Biol 2007; v14: 280-86.
240. Bagley J, Tian C, Iacomini J. Prevention of type 1 diabetes in NOD mice by genetic engineering of hematopoietic stem cells. Methods Mol Biol 2008; 433: 277-85.
241. Lei P, Andreadis ST. Efficient retroviral gene transfer to epidermal stem cells. Methods Mol Biol 2008; 433: 367-79.
242. Phillips JE, Garcia AJ. Retroviral-mediated gene therapy for the differentiation of primary cells into a mineralizing osteoblastic phenotype. Methods Mol Biol 2008; 433: 333-54.